HighField Biopharmaceuticals is a clinical-stage immunotherapy company using new liposome formulations to disrupt existing technologies for the treatment of cancer and other diseases. They develop multiple drug modalities to treat diseases by modifying the immune system. HighField Bio’s development pipeline includes liposome formulations of small molecules, antibodies, RNA, and DNA. The company has a research and developmen...
HighField Biopharmaceuticals is a clinical-stage immunotherapy company using new liposome formulations to disrupt existing technologies for the treatment of cancer and other diseases. They develop multiple drug modalities to treat diseases by modifying the immune system. HighField Bio’s development pipeline includes liposome formulations of small molecules, antibodies, RNA, and DNA. The company has a research and development center and a GMP-compliant complex injection manufacturing site.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.